Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3759390015 | Product containing ravulizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3759391016 | Ravulizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing ravulizumab in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Product containing ravulizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing ravulizumab in parenteral dose form (medicinal product form) | Is a | Product containing ravulizumab (medicinal product) | true | Inferred relationship | Some | ||
| Product containing ravulizumab in parenteral dose form (medicinal product form) | Has active ingredient | Ravulizumab (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only ravulizumab in parenteral dose form (medicinal product form) | Is a | True | Product containing ravulizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR